Financial Performance - First quarter 2025 revenue was $791 million, down 14% compared to Q1 2024, and down 10% organically[3] - The company reported a GAAP net loss of $16 million, a decline of $13 million versus Q1 2024, with adjusted earnings per diluted share of $0.18, down 50% year-over-year[4] - Adjusted EBITDA for Q1 2025 was $120 million, a decrease of 25% from the prior year, driven by lower pricing and reduced volume[4] - North America sales declined 28%, while Latin America sales grew 10%, and Asia saw a 24% revenue decline[6] - The full-year revenue outlook is maintained at $4.15 billion to $4.35 billion, essentially flat at the midpoint compared to the prior year[4] - Second quarter revenue is expected to range from $940 million to $1.10 billion, reflecting a 2% decline at the midpoint compared to Q2 2024[9] - The company anticipates a 7% increase in second-half sales compared to the same period last year, driven by growth in its portfolio and new market routes[9] - Adjusted EBITDA guidance for the full year is set at $870 million to $950 million, reflecting a 1% increase at the midpoint versus the prior year[4] - The company expects adjusted earnings per diluted share in Q2 to be between $0.52 and $0.68, representing a 5% decrease at the midpoint compared to Q2 2024[9] Cash Flow and Liquidity - Free cash flow forecast remains at $200 million to $400 million, indicating a 51% decline at the midpoint from the previous year[4] - Free cash flow for Q1 2025 was $(595.7) million, significantly lower than $(187.8) million in Q1 2024, indicating increased cash requirements[32] - Cash provided by operating activities of continuing operations was $(545.0) million in Q1 2025, a significant decline compared to $(142.9) million in Q1 2024[42] - Cash and cash equivalents decreased to $315.3 million at the end of Q1 2025 from $357.3 million at the beginning of the period, a decline of 11.8%[42] - Cash provided by financing activities of continuing operations was $552.1 million in Q1 2025, an increase from $305.7 million in Q1 2024[42] - The company reported a cash outflow from investing activities of $(38.0) million in Q1 2025, compared to $(23.7) million in Q1 2024[42] Debt and Equity - Total debt as of March 31, 2025, was $4,003.5 million, down from $4,335.7 million a year earlier, showing a reduction in leverage[37] - Long-term debt remained stable at approximately $3,027.7 million in Q1 2025, compared to $3,027.9 million in Q4 2024[40] - The equity of the company decreased to $4,411.6 million in Q1 2025 from $4,508.8 million in Q4 2024, a decline of 2.2%[40] Operational Efficiency - Adjusted after-tax earnings from continuing operations for Q1 2025 were $22.4 million, down from $45.4 million in Q1 2024, indicating a decrease of 50.7%[22] - Adjusted ROIC for the twelve months ended March 31, 2025, was 7.16%, compared to 3.85% using GAAP net income, indicating improved capital efficiency[37] - Restructuring charges for Q1 2025 amounted to $17.8 million, down from $40.9 million in Q1 2024, reflecting a decrease in restructuring activities[22] - Interest expense for Q1 2025 was $50.1 million, compared to $61.7 million in Q1 2024, indicating a reduction in financing costs[31] Assets and Liabilities - Total current assets increased to $5,077.6 million in Q1 2025 from $4,958.3 million in Q4 2024, representing a growth of 2.4%[40] - Total liabilities increased to $7,003.8 million in Q1 2025 from $6,144.5 million in Q4 2024, reflecting a rise of 14%[40] - The total assets of the company increased to $11,800.9 million in Q1 2025 from $11,653.3 million in Q4 2024, a growth of 1.3%[40] Inventory Management - Inventories rose to $1,374.4 million in Q1 2025, up from $1,201.6 million in Q4 2024, indicating an increase of 14.4%[40] Shareholder Information - The average number of shares outstanding for diluted adjusted after-tax earnings per share in Q1 2025 was 125.5 million, slightly up from 125.2 million in Q1 2024[23] - Tax adjustments for Q1 2025 totaled $14.3 million, with significant contributions from foreign currency remeasurement and other discrete items[27]

Core Insights - FMC Corporation reported a first quarter 2025 revenue of $791 million, a decrease of 14% compared to Q1 2024, with an organic decline of 10% [1][12] - The company experienced a GAAP net loss of $16 million, translating to a loss of $0.12 per diluted share, which is a decrease of $0.10 from the previous year [1][12] - Adjusted earnings per diluted share were $0.18, down 50% from Q1 2024 [1][12] Revenue and Sales Performance - First quarter sales were largely in line with expectations, with a focus on aligning inventory levels with customer targets [2] - Revenue decline was primarily driven by a 9% price decrease, with over half attributed to price adjustments in specific contracts due to lower manufacturing costs [2] - North America sales fell by 28%, while Latin America saw a 10% increase, and Asia experienced a 24% decline [3] Financial Metrics - Adjusted EBITDA for Q1 2025 was $120 million, down 25% from the prior year, influenced by lower pricing and reduced volume [4][12] - Cash from operations was negative $545 million, a decline of $402 million compared to Q1 2024, primarily due to less inventory reduction [5][12] - Free cash flow was negative $596 million, reflecting a decline of 51% at the midpoint from the previous year [12] Outlook - The company maintains its full-year 2025 revenue guidance of $4.15 billion to $4.35 billion, indicating flat growth at the midpoint compared to the prior year [6][12] - For Q2 2025, revenue is expected to range from $940 million to $1.10 billion, representing a 2% decline at the midpoint compared to Q2 2024 [7] - The second half of 2025 is projected to see a 7% increase in sales and an 11% increase in adjusted EBITDA compared to the same period last year [8][9]

Core Viewpoint - FMC Corporation has elected Steven Merkt to its Board of Directors, effective April 29, 2025, to enhance its strategic growth initiatives in the agricultural sciences sector [1][2]. Company Overview - FMC Corporation is a global agricultural sciences company focused on providing solutions for food, feed, fiber, and fuel production while adapting to environmental changes [4]. - The company emphasizes innovation in crop protection solutions, including biologicals, crop nutrition, and digital agriculture, to help growers tackle challenges economically and sustainably [4]. Leadership Appointment - Steven Merkt brings over 30 years of experience in international manufacturing, operational excellence, cybersecurity, and corporate governance [2][3]. - His previous role as president of the Transportation Solutions segment at TE Connectivity from 2012 to 2024 involved significant profitability growth and the development of a robust innovation pipeline [2]. - Merkt has held senior leadership positions in various sectors, including automotive, and has experience in managing complex Board governance issues [3]. Strategic Goals - The addition of Merkt to the Board is expected to provide valuable insights and leadership as FMC aims to strengthen its position as a global leader in agricultural sciences [2]. - Merkt expressed his commitment to accelerating FMC's mission and driving growth while ensuring operational excellence [4].

Core Viewpoint - FMC Corporation is expected to report its first-quarter 2025 results on April 30, with a history of beating earnings estimates and a trailing four-quarter earnings surprise of approximately 20.2% [1][4] Earnings Performance - FMC has consistently exceeded Zacks Consensus Estimates for earnings in the last four quarters, with an earnings surprise of 11.1% in the most recent quarter [1][2] - The Earnings ESP for FMC is +34.04%, indicating a strong likelihood of an earnings beat this quarter [4] Revenue Estimates - The Zacks Consensus Estimate for FMC's first-quarter sales is $779 million, reflecting a 15.1% year-over-year decline [7] - Revenue estimates for different regions include: - North America: $224.2 million, a 13.4% decline [7] - Latin America: $137.9 million, a 26.6% decline [7] - EMEA: $278.5 million, a 9.2% decline [8] - Asia: $144.8 million, an 11.8% decline [8] Factors Influencing Performance - FMC is expected to benefit from new product launches and cost-control measures, which are anticipated to support its performance despite challenges [2][9] - The company is focusing on expanding its product portfolio and has seen strong sales from its growth portfolio, including new active ingredients [9] - Cost reductions and a favorable product mix are expected to positively impact margins, with restructuring actions projected to yield $165 million in adjusted EBITDA for full-year 2024 and over $225 million in savings by the end of 2025 [10] Challenges Faced - FMC is likely to encounter challenges from inventory de-stocking and pricing pressures, which may negatively affect volumes and revenues [11][12] - The company projects first-quarter revenues in the range of $750-$800 million, indicating a 16% decrease at the midpoint compared to the same period in 2024 [11] - Weaker prices are expected to continue impacting revenues, with a mid-to-high single-digit price decline anticipated due to adjustments in partner contracts [12]

The market expects FMC (FMC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 30 ...

Group 1: Leadership Transition - FMC Corporation announced the retirement of Michael F. Reilly after 23 years with the company, effective July 1, 2025 [1] - Sara Velazquez Ponessa has been appointed as the new executive vice president, general counsel, and corporate secretary, effective June 1, 2025 [1] - Reilly's tenure included significant contributions to FMC's transformation into a focused agricultural sciences company, overseeing strategic initiatives, acquisitions, and divestitures [1][2] Group 2: New General Counsel's Background - Ponessa previously served as senior business counsel at FMC from 2012 to 2018 and has extensive legal experience, including her role as general counsel at Livent Corporation [2][3] - At Livent, she led the legal aspects of the company's successful 2018 IPO and its 2019 spinoff from FMC [2] - Most recently, Ponessa was vice president, general counsel, and secretary at Arcadium Lithium plc, managing global legal and compliance functions [2][3] Group 3: Transition Support - Reilly will support Ponessa in her new role starting April 28 to ensure a smooth transition [4] Group 4: Company Overview - FMC Corporation is a global agricultural sciences company focused on providing innovative crop protection solutions to help growers meet the challenges of food production while protecting the environment [5]

FMC Corporation (FMC) has received regulatory approvals for its Keenali herbicide, powered by Dodhylex active, in Peru. With this approval, FMC’s first active ingredient and commercial product has received global registration for this breakthrough herbicide technology. Dodhylex active is the first and only herbicide to be classified as a Group 28 herbicide by the Herbicide Resistance Action Committee and the Weed Science Society of America.This marks a huge step in the field of agricultural innovation and s ...

Core Insights - FMC Corporation has received regulatory approval for Keenali™ herbicide in Peru, marking the first global registration of this innovative herbicide technology powered by Dodhylex™ active [1][3] - Keenali™ herbicide is designed for pre- and early post-emergence application, offering excellent crop safety and broad utility in both Japonica and Indica rice varieties [2][3] - The approval is significant for Peruvian rice growers, providing an effective solution for managing resistant grass weeds without compromising crop safety [3] Company Overview - FMC Corporation is a global leader in agricultural sciences, focusing on innovative crop protection solutions to support food security and address modern agricultural challenges [6] - The company has a commitment to advancing new herbicide technologies, with Dodhylex™ active being a key development in combating weed resistance [5][6] Market Opportunity - Peru is identified as a rapidly growing market for rice production, with over 4.5 million planted hectares of rice across Latin America, unlocking nearly 10% of these hectares for Keenali™ herbicide [4] - FMC is actively pursuing regulatory approvals for Dodhylex™ active in other Latin American countries and regions, including Brazil, Colombia, and India, indicating a strategic expansion plan [4]

NEW YORK, April 14, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FMC Corporation (NYSE: FMC) between November 16, 2023 and February 4, 2025, both dates inclusive (the "Class Period"), of the important April 14, 2025 lead plaintiff deadline.So what: If you purchased FMC securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To ...

Core Viewpoint - A class action lawsuit has been filed against FMC Corporation for alleged violations of securities laws, specifically related to misleading statements made to investors during the class period from November 16, 2023, to February 4, 2025 [1][2][4]. Group 1: Lawsuit Details - The Schall Law Firm is representing investors in a class action lawsuit against FMC Corporation for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased FMC's securities during the specified class period are encouraged to contact the law firm before April 14, 2025, to discuss their rights [2][3]. - The lawsuit claims that FMC made false and misleading statements regarding its channel management initiatives and failed to compete on price, leading to inflated inventories in various regions including LATAM, Asia, Canada, and Eastern Europe [4]. Group 2: Impact on Investors - The misleading public statements made by FMC resulted in damages to investors once the truth about the company's situation was revealed [4]. - The class action has not yet been certified, meaning that potential class members are not currently represented by an attorney unless they take action [3].